Nihon Kohden (OTCMKTS:NHNKY) Trading 9.2% Higher - Here's What Happened

Key Points

• Nihon Kohden Corporation experienced a 9.2% increase in stock price during trading on Monday, with shares reaching a high of $12.21.
• The company reported a net margin of 5.77% and earnings of $0.01 EPS for the last quarter, with revenues totaling $346.24 million.
• Nihon Kohden specializes in the development and sale of medical electronic equipment, including patient monitoring systems and treatment equipment like defibrillators and ventilators.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) was up 9.2% during trading on Monday . The stock traded as high as $12.21 and last traded at $12.21. Approximately 3,784 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 5,462 shares. The stock had previously closed at $11.18.

Nihon Kohden Trading Up 4.6%

The stock has a fifty day simple moving average of $12.08 and a two-hundred day simple moving average of $12.98. The firm has a market cap of $2.00 billion, a PE ratio of 21.65 and a beta of 0.34.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter. Nihon Kohden had a return on equity of 6.80% and a net margin of 5.77%. The business had revenue of $346.24 million during the quarter.

Nihon Kohden Company Profile

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.